Author: Scott Welch
Drugs known as statins are the first-choice treatment for high cholesterol but millions of people who can’t or won’t take those pills because of side effects may have another option. In a major study, a different kind of cholesterol-lowering drug named Nexletol reduced the risk of heart attacks and some other cardiovascular problems in people ...
When the covid-19 pandemic swept the country in early 2020 and emptied doctors’ offices nationwide, telemedicine was suddenly thrust into the spotlight. Patients and their physicians turned to virtual visits by video or phone rather than risk meeting face-to-face. During the early months of the pandemic, telehealth visits for care exploded. “It was a dramatic shift ...
A low-carb, high-fat “keto-like” diet may be linked to higher levels of “bad” cholesterol and double the risk of cardiovascular events such as blocked arteries, heart attacks and strokes, according to new research. “Our study found that regular consumption of a self-reported diet low in carbohydrates and high in fat was associated with increased levels ...
Thousands of Nevadans could lose their no-cost Medicaid health coverage this year as pandemic emergency provisions wind down, according to state officials. Following a three-year grace period during the worst of COVID-19, Medicaid recipients will be required to reapply for benefits beginning April 1.
To solve Nevada’s doctor shortage, one Las Vegas lawmaker proposes helping doctors pay off student debt in exchange for working in the Silver State, all in an effort to help lure more medical professionals.
The 14-day average for new daily confirmed cases dipped to 86 in the county from 91 a week ago, according to data posted Wednesday by the Nevada Department of Health and Human Services. Statewide, the average decreased to 126 from 135.
Self-insured employers view the cost of specialty drugs as a major challenge in providing health benefits, according to a survey released yesterday by the Midwest Business Group on Health (MBGH). Cheryl Larson, MBGH’s president and CEO, told Fierce Healthcare that “the new million-dollar treatments approved by the FDA; 30 of our employers said that this is a ...
Eli Lilly announced Wednesday a series of price cuts that would lower the price of the most commonly used forms of its insulin 70% and said it will automatically cap out-of-pocket insulin costs at $35 for people who have private insurance and use participating pharmacies.
Dive Brief: Arbiters can resume resolving payment disputes between providers and payers involving cases in which care was delivered prior to Oct. 25, the CMS said Friday. However, the arbitration process to is still on hold for disputes regarding services delivered on or after that date, following a federal judge’s decision earlier this month. The CMS is ...
Doctors, public health experts, and even Democratic members of Congress are sounding the alarm on a new Biden administration proposal to restrict access to a key addiction-treatment medication. The proposal would curtail access via telehealth to buprenorphine, a common and highly effective drug used to treat opioid use disorder. While doctors can currently give out both new ...